Affordable Access

deepdyve-link
Publisher Website

Laparoscopic versus hybrid approach for treatment of incisional ventral hernia: a prospective randomised multicentre study, 1-year results.

Authors
  • Ahonen-Siirtola, Mirella1, 2
  • Nevala, Terhi3
  • Vironen, Jaana4
  • Kössi, Jyrki5
  • Pinta, Tarja6
  • Niemeläinen, Susanna7
  • Keränen, Ulla4
  • Ward, Jaana5
  • Vento, Pälvi8
  • Karvonen, Jukka9
  • Ohtonen, Pasi10
  • Mäkelä, Jyrki10
  • Rautio, Tero10
  • 1 Department of Surgery, Oulu University Hospital, Oulu, Finland. [email protected] , (Finland)
  • 2 Division of Gastroenterology, Department of Surgery, Oulu University Hospital, OYS, PL 21, 90029, Oulu, Finland. [email protected] , (Finland)
  • 3 Department of Radiology, Oulu University Hospital, Oulu, Finland. , (Finland)
  • 4 Department of Surgery, Helsinki University Hospital, Helsinki, Finland. , (Finland)
  • 5 Department of Surgery, Päijät-Häme Central Hospital, Lahti, Finland. , (Finland)
  • 6 Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland. , (Finland)
  • 7 Department of Surgery, Valkeakoski Regional Hospital, Valkeakoski, Finland. , (Finland)
  • 8 Department of Surgery, Kymenlaakso Central Hospital, Kotka, Finland. , (Finland)
  • 9 Department of Surgery, Turku University Hospital, Turku, Finland. , (Finland)
  • 10 Department of Surgery, Oulu University Hospital, Oulu, Finland. , (Finland)
Type
Published Article
Journal
Surgical Endoscopy
Publisher
Springer-Verlag
Publication Date
Jan 01, 2020
Volume
34
Issue
1
Pages
88–95
Identifiers
DOI: 10.1007/s00464-019-06735-9
PMID: 30941550
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Laparoscopic incisional ventral hernia repair (LIVHR) is often followed by seroma formation, bulging and failure to restore abdominal wall function. These outcomes are risk factors for hernia recurrence, chronic pain and poor quality of life (QoL). We aimed to evaluate whether LIVHR combined with defect closure (hybrid) follows as a diminished seroma formation and thereby has a lower rate of hernia recurrence and chronic pain compared to standard LIVHR. This study is a multicentre randomised controlled clinical trial. From November 2012 to May 2015, 193 patients undergoing LIVHR for primary incisional hernia with fascial defect size from 2 to 7 cm were recruited in 11 Finnish hospitals. Patients were randomised to either a laparoscopic (LG) or a hybrid (HG) repair group. The main outcome measure was hernia recurrence, evaluated clinically and radiologically at a 1-year follow-up visit. At the same time, chronic pain scores and QoL were also measured. At the 1-year-control visit, we found no difference in hernia recurrence between the study groups. Altogether, 11 recurrent hernias were found in ultrasound examination, producing a recurrence rate of 6.4%. Of these recurrences, 6 (6.7%) were in the LG group and 5 (6.1%) were in the HG group (p > 0.90). The visual analogue scores for pain were low in both groups; the mean visual analogue scale (VAS) was 1.5 in LG and 1.4 in HG (p = 0.50). QoL improved significantly comparing preoperative status to 1 year after operation in both groups since the bodily pain score increased by 7.8 points (p < 0.001) and physical functioning by 4.3 points (p = 0.014). Long-term follow-up is needed to demonstrate the potential advantage of a hybrid operation with fascial defect closure. Both techniques had low hernia recurrence rates 1 year after operation. LIVHR reduces chronic pain and physical impairment and improves QoL. Clinical trial number NCT02542085.

Report this publication

Statistics

Seen <100 times